Takeda GmbH v Actegy Limited

Takeda GmbH (Takeda) and Actegy Limited (Actegy) were parties to a dispute before the Federal Court of Australia. The core of the disagreement concerned the validity and infringement of Takeda's Australian Patent No. 2012270017 (the Patent), which related to a method for treating or preventing a specific medical condition. Takeda alleged that Actegy had infringed the Patent through its sale of certain medical devices. Actegy, in turn, sought to invalidate the Patent on several grounds.

The primary legal issues before the Court were whether the Patent was valid, and if so, whether Actegy had infringed its claims. Specifically, the Court was required to consider whether the Patent satisfied the requirements of novelty and inventive step, and whether the claims as construed were infringed by Actegy's products. Actegy also raised arguments concerning the sufficiency of the Patent's disclosure and whether the Patent was otherwise invalid.

Justice Wilson found that Actegy had infringed the Patent. The Court determined that the Patent was valid, having satisfied the requirements of novelty and inventive step. In reaching this conclusion, the Court applied established principles of patent law, including the assessment of prior art and the assessment of obviousness. The Court also considered the proper construction of the patent claims and found that Actegy's products fell within the scope of those claims.

Consequently, the Court ordered that Actegy had infringed the Patent and that the Patent was valid. The parties were directed to make submissions on the question of relief, including an injunction and an award of damages or an account of profits.